Cargando…
Unleashing implementation research to accelerate national noncommunicable disease responses
Noncommunicable diseases (NCDs) are the leading cause of death and disability worldwide. They exact a disproportionate toll in low and middle-income countries, and the world is not on-track to meet international targets for reductions in premature NCD mortality. Largely, we know which policies work...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785572/ https://www.ncbi.nlm.nih.gov/pubmed/35073947 http://dx.doi.org/10.1186/s12992-021-00790-5 |
_version_ | 1784638991156379648 |
---|---|
author | Collins, Tea Akselrod, Svetlana Berlina, Daria Allen, Luke N |
author_facet | Collins, Tea Akselrod, Svetlana Berlina, Daria Allen, Luke N |
author_sort | Collins, Tea |
collection | PubMed |
description | Noncommunicable diseases (NCDs) are the leading cause of death and disability worldwide. They exact a disproportionate toll in low and middle-income countries, and the world is not on-track to meet international targets for reductions in premature NCD mortality. Largely, we know which policies work for tackling NCDs, and the World Health Organization (WHO) has developed a package of ‘best buy’ policies that are highly cost effective. However, we don’t necessarily know how to adapt and implement these policies in new populations and cultures. Implementation Research (IR) is emerging as a potent tool for gearing the international response, providing a scientific approach to study the processes used to implement policies and interventions and the contextual factors that affect these processes. Amidst growing interest from policymakers, we identify four main areas for action: high-level engagement with IR among international NCD leaders; domestic investment in technical capacity-building; the creation of new financing streams for IR research; and the development of multi-stakeholder engagement mechanisms that can convene and leverage the perspectives and resources of multiple actors with overlapping aims. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12992-021-00790-5. |
format | Online Article Text |
id | pubmed-8785572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87855722022-01-24 Unleashing implementation research to accelerate national noncommunicable disease responses Collins, Tea Akselrod, Svetlana Berlina, Daria Allen, Luke N Global Health Commentary Noncommunicable diseases (NCDs) are the leading cause of death and disability worldwide. They exact a disproportionate toll in low and middle-income countries, and the world is not on-track to meet international targets for reductions in premature NCD mortality. Largely, we know which policies work for tackling NCDs, and the World Health Organization (WHO) has developed a package of ‘best buy’ policies that are highly cost effective. However, we don’t necessarily know how to adapt and implement these policies in new populations and cultures. Implementation Research (IR) is emerging as a potent tool for gearing the international response, providing a scientific approach to study the processes used to implement policies and interventions and the contextual factors that affect these processes. Amidst growing interest from policymakers, we identify four main areas for action: high-level engagement with IR among international NCD leaders; domestic investment in technical capacity-building; the creation of new financing streams for IR research; and the development of multi-stakeholder engagement mechanisms that can convene and leverage the perspectives and resources of multiple actors with overlapping aims. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12992-021-00790-5. BioMed Central 2022-01-24 /pmc/articles/PMC8785572/ /pubmed/35073947 http://dx.doi.org/10.1186/s12992-021-00790-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Collins, Tea Akselrod, Svetlana Berlina, Daria Allen, Luke N Unleashing implementation research to accelerate national noncommunicable disease responses |
title | Unleashing implementation research to accelerate national noncommunicable disease responses |
title_full | Unleashing implementation research to accelerate national noncommunicable disease responses |
title_fullStr | Unleashing implementation research to accelerate national noncommunicable disease responses |
title_full_unstemmed | Unleashing implementation research to accelerate national noncommunicable disease responses |
title_short | Unleashing implementation research to accelerate national noncommunicable disease responses |
title_sort | unleashing implementation research to accelerate national noncommunicable disease responses |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785572/ https://www.ncbi.nlm.nih.gov/pubmed/35073947 http://dx.doi.org/10.1186/s12992-021-00790-5 |
work_keys_str_mv | AT collinstea unleashingimplementationresearchtoacceleratenationalnoncommunicablediseaseresponses AT akselrodsvetlana unleashingimplementationresearchtoacceleratenationalnoncommunicablediseaseresponses AT berlinadaria unleashingimplementationresearchtoacceleratenationalnoncommunicablediseaseresponses AT allenluken unleashingimplementationresearchtoacceleratenationalnoncommunicablediseaseresponses |